COMMUNIQUÉS West-GlobeNewswire

FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher

12/06/2018 - 14:30

BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the U.S. Food and Drug [...]

Yield Endurance Strategic Partner Closes on Loan of 100 Bitcoins

12/06/2018 - 14:30

JERSEY CITY, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc.’s (OTCQB:SENZ) wholly-owned subsidiary, Yield Endurance, Inc. (“Yield”), today announced that its strategic business partner, Madison Partners [...]

Stealth Mark to Provide Automated Platform Version of ActiveDuty Intelligence System

12/06/2018 - 14:30

HOFFMAN ESTATES, IL, June 12, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI) today announced its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, has released plans to offer a specialized, [...]

Cytori Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering

12/06/2018 - 14:30

SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) ("Cytori"), today provided an informational update to stockholders regarding its proposed rights offering and the expected key dates [...]

Chiesi and Holostem Announce FDA Orphan Drug Designation for GPLSCD01 for treatment of Limbal Stem Cell Deficiency (LSCD)

12/06/2018 - 14:00

Investigational therapy uses individual patient’s own stem cells to potentially regenerate and repair damaged eye tissue CARY, N.C., June 12, 2018 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee) , a specialty pharmaceutical [...]

resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development

12/06/2018 - 14:00

Newly Created Position Strategically Expands Development Capabilities BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC) today announced that Kerry Russell, M.D., Ph.D., has joined the company as [...]

Progressive Care Launches Opioid Alternative Treatment Campaign Aimed at Reaching Millions Affected by the Nationwide Epidemic

12/06/2018 - 14:00

MIAMI, June 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today launched a new program designed to educate patients and providers on [...]

GeneDx Announces Completion of 100,000 Exome Sequences

12/06/2018 - 14:00

Milestone achievement offers significant contribution to clinically relevant genetic variants used to diagnose rare and genetic diseases GAITHERSBURG, Md., June 12, 2018 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of [...]

Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site

12/06/2018 - 14:00

EAST RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it [...]

Nu-Med Plus, Inc. engages Millennium Biosciences for Quality and Regulatory consulting services

12/06/2018 - 14:00

SALT LAKE CITY, June 12, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCQB:NUMD), a medical device company which investigates and develops applications of Nitric Oxide technologies in the medical field, has selected [...]

Matinas BioPharma to Present at the 20th ICHS Symposium on Infections in the Immunocompromised Host

12/06/2018 - 14:00

BEDMINSTER, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its [...]

Opiant Pharmaceuticals Appoints Biotech and Pharmaceutical Industry Veteran Richard Daly to Board of Directors

12/06/2018 - 14:00

SANTA MONICA, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced the [...]

Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer

12/06/2018 - 14:00

Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery businesses RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a [...]

Lotus Purchases 23-Acre Cannabis Facility Site in Armstrong BC

12/06/2018 - 14:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc. (CSE:J) has exercised the option to purchase [...]

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

12/06/2018 - 14:00

NEW HAVEN, Conn., June 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the recommendations of the [...]

OncoMed Doses First Patient in Phase 1b Portion of anti-TIGIT Clinical Trial

12/06/2018 - 14:00

Expanded Phase of Trial will Assess anti-TIGIT in Combination with anti-PD1 REDWOOD CITY, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company [...]

Bellerophon Therapeutics to Participate on Panel at JMP Securities Life Sciences Conference

12/06/2018 - 14:00

WARREN, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it will participate on a [...]

Tyme Releases Detailed Data and Analyses with SM-88 From the First Human Study and Compassionate Use Programs

12/06/2018 - 14:00

NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage biotechnology company developing cancer therapeutics, today release detailed patient data and analyses from both the [...]

Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic Testing Program for People with Suspected Hereditary ATTR Amyloidosis

12/06/2018 - 13:45

hATTR Compass to provide no-cost, confidential genetic testing and genetic counseling services, potentially enabling faster diagnosis CAMBRIDGE, Mass., June 12, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq: [...]